Institutional investors purchased a net $4.5 million shares of FOLD during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 45.70% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
REDMILE GROUP LLC Bought 6.2 Million shares of Amicus Therapeutics Inc